4:45 PM ET
10-Q
Financial Results
Standard Biotools Q3 2026 Results: Turns Profitable, Net Income $13.5M
Standard BioTools reported a net income of $113.8 million for the nine months ended September 30, 2026, primarily driven by a $202.3 million gain on the sale of a business recorded in discontinued operations. However, the company experienced a loss from continuing operations of $57.7 million during the same period, reflecting ongoing restructuring and integration expenses.
- Key figure
- Net income $13.5M